How has GoodRx Holdings, Inc.'s equity method investments (note 11) changed year-over-year?

GoodRx Holdings, Inc.'s equity method investments (note 11) decreased by 0.0% year-over-year, from $15M to $15M.

What is the long-term trend for GoodRx Holdings, Inc.'s equity method investments (note 11)?

Over 3 years (2022 to 2025), GoodRx Holdings, Inc.'s equity method investments (note 11) has grown at a -7.6% compound annual growth rate (CAGR), from $19M to $15M.

GoodRx Holdings, Inc. GDRX Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

UnitedHealth GroupUNH

——

Other financials

Income statement

See full

Revenue$194.0M-4.4%

Gross profit$173.9M-8.3%

Operating income$14.0M-40.1%

Net income$1.2M-89.4%

EPS (diluted)$0.00-100%

Balance sheet

See full

Cash & equivalents$235.7M-21.7%

Total debt$541.4M0.0%

Total equity$622.0M-4.9%

Total assets$2.0B+56.0%

Cash flow

See full

Operating cash flow$11.8M+25.8%

CapEx$1.1M+700%

Free cash flow$10.7M+15.4%

Valuation

See full

Market cap$911.04M-44.5%

Enterprise value$1.22B-35.4%

P/E44.3×-13.4×

P/S1.2×-0.9×

Profitability

See full

Gross margin91.8%-2.0pp

Operating margin9.9%-0.3pp

Net margin2.6%-1.0pp

FCF margin21%+2.3pp

Returns & leverage

See full

Return on equity3.2%-1.2pp

Debt / equity0.9×0.0×

Current ratio1.5×-3.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about GoodRx Holdings, Inc.'s equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is GoodRx Holdings, Inc.'s equity method investments (note 11)?: GoodRx Holdings, Inc. (GDRX) reported equity method investments (note 11) of $15M in Q1 2026.
How has GoodRx Holdings, Inc.'s equity method investments (note 11) changed year-over-year?: GoodRx Holdings, Inc.'s equity method investments (note 11) decreased by 0.0% year-over-year, from $15M to $15M.
What is the long-term trend for GoodRx Holdings, Inc.'s equity method investments (note 11)?: Over 3 years (2022 to 2025), GoodRx Holdings, Inc.'s equity method investments (note 11) has grown at a -7.6% compound annual growth rate (CAGR), from $19M to $15M.